Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.
about
Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain SocietyThe effects of chemical and physical penetration enhancers on the percutaneous permeation of lidocaine through equine skin.Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society.Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability.Diagnosing and managing postherpetic neuralgia.Options for treating postherpetic neuralgia in the medically complicated patient.Review of current guidelines on the care of postherpetic neuralgia.Management of chronic noncancer pain in depressed patients.Coanalgesics for chronic pain therapy: a narrative review.Management of pain in the elderly at the end of life.Management of severe neuropathic cancer pain: an illustrative case and review.Strategies for delivering local anesthetics to the skin: focus on liposomes, solid lipid nanoparticles, hydrogels and patches.Pharmacological Management of Cancer-Related Pain.Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients.Effect of 5% lidocaine medicated plaster on pain intensity and paroxysms in classical trigeminal neuralgia.Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases.Lidocaine 5 % patches as an effective short-term co-analgesic in cancer pain. Preliminary results.Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus statement.Pharmacokinetics of a lidocaine patch 5% in dogs.Management of chronic neuropathic pain with single and compounded topical analgesics.
P2860
Q24657295-908F167D-6D39-4E96-A58B-BB0BE19386BAQ33832173-EA038193-E5F0-491C-8076-868DA6C76CECQ34756198-FB8010F7-9851-4C31-9746-D5AB410906A6Q35077720-C69CDD8B-6A58-463B-BDC2-8C034B87083DQ35752545-F5B05E18-E264-4ACD-90A5-9B08365948B7Q36956756-8747C88A-21E6-4475-8278-CE8F0AAE4E2BQ37120711-426E5529-F859-4E1B-A1A6-4CD7A6AA40AAQ37929504-BDA9F250-8989-4659-99D4-33FCCC8EF7DAQ37929505-6C6F3D8D-40CA-47EB-8B0B-35B31FABB670Q37959164-0A71F949-3715-46AD-925A-E87B8D436FFCQ37998511-7ABC8C7C-D382-424A-8C69-A43FF4AEDED1Q38002778-1D02D2BE-5BFF-4A90-8A39-829DA44E9A10Q38128339-D2DC7BB9-BAE2-4448-BFEE-4AEF9F685B03Q38672359-5CB4BCD3-271C-4444-9757-D87167085D2CQ39025692-9919CB98-37D9-4493-B8B5-F418EBFD816DQ39152528-36FC4721-293D-47A3-9870-A828E7E40877Q39322000-E7E90CB1-D058-4040-B62D-5E482CE8AEB5Q42616506-190FF341-2014-45FF-970F-AC0AC2192F04Q47161733-A9A2B5B2-BF12-4683-997B-26EC7B1F1CA1Q48733744-97841A78-B023-451D-9741-8EE5FAF20B9CQ50072130-2CE85A63-39F7-44E0-9966-AFB98775A345
P2860
Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.
@en
type
label
Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.
@en
prefLabel
Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.
@en
P2860
P356
P1476
Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing.
@en
P2093
Arnold R Gammaitoni
Matthew W Davis
P2860
P304
P356
10.1345/APH.1A185
P407
P577
2002-02-01T00:00:00Z